Correlation of VEGF expression by leukocytes with the growth and regression of blood vessels in the rat cornea

Investigative Ophthalmology and Visual Science

Volumn 40, Issue 6, 1999, Pages 1112-1123

  Edelman, Jeffrey L ^a   Castro, Marisol R ^a   Wen, Yi ^b  

^a ALLERGAN INC   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; MESSENGER RNA; PARAFORMALDEHYDE; SILVER NITRATE; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CORNEA VASCULARIZATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HYPEROXIA; IMMUNOHISTOCHEMISTRY; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING;

ANIMALS; BLOOD VESSELS; CAUTERY; CORNEA; DEXAMETHASONE; ENDOTHELIAL GROWTH FACTORS; FEMALE; FIBROBLAST GROWTH FACTOR 2; GLUCOCORTICOIDS; HYPEROXIA; LEUKOCYTES; LYMPHOKINES; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0032923781     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Alvarez JA, Baird A, Tatum A, et al. Localization of basic fibroblast growth factor and vascular endothelial growth factor in human glial neoplasms. Mod Pathol. 1992;5:303-307.
2. Miller JW, Adamis AP, Shima DT, et al. Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Am J Pathol. 1994;145:574-584.
3. Kolch W, Martiny-Baron G, Kieser A, Dieter M. Regulation of the expression of the VEGF/VPS and its receptors: role in tumor angiogenesis. Breast Cancer Res Treat. 1995;36:139-155.
4. Pierce EA, Avery RL, Foley ED, Aiello LP, Smith LE. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci. 1995;92:905-909.
5. Amano S, Roban R, Kuroki M, Tolentino M, Adamis AP. Requirement for vascular endothelial growth factor in wound- and inflammation-related corneal neovascularization. Invest Ophthalmol Vis Sci. 1998;39:18-22.
6. Caffery BE, Josephson JE. Corneal vascularization. Optom Clin. 1995;4:19-29.
7. Glatt HJ, Klintworth GK. Quantitation of neovascularization in flat preparations of the cornea. Microvasc Res. 1986;31:104-109.
8. Proia AD, Chandler DB, Haynes WL, Smith CF, Suvarnamani C, Erkel FH, Klintworth GK. Quantitation of corneal neovascularization using computerized image analysis. Lab Invest. 1988;58:473-479.
9. Ross LL, Danehower SC, Proia AD, et al. Coordinated activation of corneal wound response genes in vivo as observed by in situ hybridization. Exp Eye Res. 1995;61:435-450.
10. Proia AD, Hirakata A, McInnes JS, Scroggs MW, Parikh I. The effect of angiostatic steroids and β-cyclodextrin tetradecasulfate on corneal neovascularization in the rat. Exp Eye Res. 1993;57:693-698.
11. Fromer CH, Klintworth GK. An evaluation of the role of leukocytes in the pathogenesis of experimentally induced corneal vascularization, I: comparison of experimental models of corneal neovascularization. Am J Pathol. 1975;79:537-554.
12. Fromer CH, Klintworth GK. An evaluation of the role of leukocytes in the pathogenesis of experimentally induced corneal vascularization, II: studies on the effect of leukocytic elimination on corneal vascularization. Am J Pathol. 1975;81:531-544.
13. Fromer CH, Klintworth GK. An evaluation of the role of leukocytes in the pathogenesis of experimentally induced corneal vascularization, III: studies related to the vasoproliferative capability of polymorphonuclear leukocytes and lymphocytes. Am J Pathol. 1976;82:157-170.
14. Knighton DR, Phillips GD, Fiegel VD. Wound healing angiogenesis: indirect stimulation by basic fibroblast growth factor. J Trauma. 1990;30:S134-S144.
15. Phillips GD, Stone AM, Jones BD, Schultz JC, Whitehead RA, Knighton DR. Vascular endothelial growth factor (rhVEGF165) stimulates direct angiogenesis in the rabbit cornea. In Vivo. 1994; 8:961-965.
16. Hsu HY, Nicholson AC, Hajjar DP. Basic fibroblast growth factor- induced low density lipoprotein receptor transcription and surface expression: signal transduction pathways mediated by the bFGF receptor tyrosine kinase. J Biol Chem. 1994;269:9213-9220.
17. Nguyen HC, Steinberg BM, LeBoutillier M, et al. Suppression of neointimal lesions after vascular injury: a role for polyclonal anti-basic fibroblast growth factor antibody. Surgery. 1994;116:456-461.
18. Rogelj S, Klagsbrun M, Atzmon R, et al. Basic fibroblast growth factor is an extracellular matrix component required for supporting the proliferation of vascular endothelial cells and the differentiation of PC 12 cells. J Cell Biol. 1989;109:823-831.
19. Nissen NN, Polverini PJ, Gamelli RL, DiPietro LA. Basic fibroblast growth factor mediates angiogenic activity in early surgical wounds. Surgery. 1996;119:457-465.
20. Clause M, Weich H, Breier G, et al. The vascular endothelial growth factor receptor Fit-1 mediates biological activities: implications for a functional role of placenta growth factor in monocyte activation and chemotaxis. J Biol Chem. 1996;271:17629-17634.
21. Senger DR, Perruzzi CA, Feder J, Dvorak HF. A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. Cancer Res. 1986;46:5629-5632.
22. Koch AE, Harlow LA, Haines GK, et al. Vascular endothelial growth factor: a cytokine modulating endothelial function in rheumatoid arthritis. J Immunol. 1994;152:4149-4156.
23. Ben-Av P, Crofford LJ, Wilder RL, Hla T. Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1: a potential mechanism for inflammatory angiogenesis. FEBS Lett. 1995;372:83-87.
24. Levy AP, Levy NS, Goldberg MA. Post-transcriptional regulation of vascular endothelial growth factor by hypoxia. J Biol Chem. 1996; 271:2746-2753.
25. Gaudry M, Bregerie O, Andrieu V, El Benna J, Pocidalo MA, Hakim J. Intracellular pool of vascular endothelial growth factor in human neutrophils. J Blood. 1997;90:4153-4161.
26. Castro MR, Edelman JL. Temporal relationship between vascular endothelial growth factor (VEGF) and angiogenesis in the rat cornea following chemical cautery and their modulation by dexamethasone and oxygen [ARVO Abstract]. Invest Ophthalmol Vis Sci. 1998;39(4):S744. Abstract nr 3422.
27. El-Husseini AE, Paterson JA, Shiu RPC. Basic fibroblast growth factor (bFGF) and two of its receptors, FGFR1 and FGFR2: gene expression in the rat brain during postnatal development as determined by quantitative RT-PCR. Mol Cell Endocrinol. 1994;104:191-200.
28. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
29. Wen Y, Li GW, Chen P, Wong E, Bekhor I. Lens epithelial cell mRNA, II: expression of a mRNA encoding a lipid-binding protein in rat lens epithelial cells. Gene. 1995;158:269-274.
30. Burger PC, Klintworth GK. Autoradiographic study of corneal neovascularization induced by chemical cautery. Lab Invest. 1981; 45:328-335.
31. Nauck M, Roth M, Tamm M, et al. Induction of vascular endothelial growth factor by platelet-activating factor and platelet-derived growth factor is downregulated by corticosteroids. Am J Respir Cell Mol Biol. 1997;16:398-406.
32. Pournaras CJ, Miller JW, Gragoudas ES, et al. Systemic hyperoxia decreases vascular endothelial growth factor gene expression in ischemic primate retina. Arch Ophthalmol. 1997;115:1553-1558.
33. Bikfalvi A, Dupuy E, Inyang AL, et al. Binding, internalization, and degradation of basic fibroblast growth factor in human microvascular endothelial cells. Exp Cell Res. 1989;181:75-84.
34. Rieck P, Hartmann C, Jacob C, Pouliquen Y, Courtois Y, Human recombinant bFGF stimulates corneal endothelial wound healing in rabbits. Curr Eye Res. 1992;11:1161-1172.
35. 2+ and von Willebrand factor release in human endothelial cells. Am J Pathol. 1991;138:213-221.
36. Couper LL, Bryant SR, Eldrup-Jorgensen J, Bredenberg CE, Lindner V. Vascular endothelial growth factor increases the mitogenic response to fibroblast growth factor-2 in vascular smooth muscle cells in vivo via expression of fms-like tyrosine kinase-1. Circ Res. 1997;81:932-939.
37. Barleon B, Sozzani S, Zhou D, Weich HA, Mantovani A, Marme D. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood. 1996;87:3336-3343.
38. Gerber HP, Condorelli F, Park J, Ferrara N. Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia. J Biol Chem. 1997;272:23659-23667.
39. Koch AE, Polverini PJ, Kunkel SL, et al. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science. 1992;258:1798-1801.
40. Sunderkotter C, Steinbrink K, Goebeler M, Bhardwaj R, Sorg C. Macrophages and angiogenesis. J Leukoc Biol. 1994;55:410-422.
41. Alon T, Hemo I, Itin A, Pe'er J, Stone J, Keshet E. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med. 1995;1:1024-1028.
42. Kawai K, Yamada M, Haa Y, Mashima Y, Hirakata A. The role of cyclooxgenase-2 induced by chemical cautery in corneal angiogenesis in the rat [ARVO Abstract]. Invest Ophthalmol Vis Sci. 1998; 39(4):S743. Abstract nr 3416.
43. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis Nature. 1992;359:843-845.